S. Sakura Minami
Vice President, Translational Medicine & Nonclinical Development Iron Fist Therapeutics
Seminars
Thursday 23rd July 2026
Panel Discussion: Shaping the Future of Combination Radioligand Therapy: Preclinical Perspectives
2:30 pm
- Balancing toxicity and efficacy: minimizing radiopharmaceutical dose while enhancing tumor kill
- Timing combination therapies: strategies for preclinical-to-clinical translation
- Selecting patients using biomarkers to match optimal RLT combinations with tumor and TME characteristics
Wednesday 22nd July 2026
Modulating Tumor Microenvironment– Mediated Resistance Mechanisms to Enhance Therapeutic Response in Preclinical Models
12:00 pm
- Immune modulation of the TME as a strategy to enhance anti-tumor immunity
- Combinatorial therapeutic strategies to leverage TME modulation with anti-tumor immunotherapies
- Targeting the TME with preclinical interventions
